Careers LGP Global

Home
About Us
Projects
Investor Centre
Media
- Media
Contact
- Contact Details
- Newsletter sign up

Home
About Us
Projects
Investor Centre
Media
Contact

Menu Section List

Investor Centre

Investor Centre

Information to assist those interested in investing in Little Green Pharma Ltd.

Home > Investor Centre > ASX Announcements

Share Purchase Plan (SPP)
Investor Welcome
Investor Presentations
ASX Announcements
Quarterly Reports
Annual & Half Yearly Reports
Corporate Governance Statement
Annual General Meetings
- Market Research
Extraordinary General Meetings
Corporate Directory
Cannabis wrap
ASIC Guidance
Share Price Information
Email Alerts

ASX Announcements

Filter by Year:2024 2023 2022 2021

21 Feb 2024

Results of General Meeting and appointment of auditor

19 Feb 2024

Final Appendix 3A.5

19 Feb 2024

Reset Offers withdrawn and Reset to remain LGP subsidiary

08 Feb 2024

Investor Webinar & December Quarterly Results Presentation

01 Feb 2024

LGP receives $5 million R&D rebate

31 Jan 2024

Quarterly Activities Report & Appendix 4C

17 Jan 2024

Updated Appendix 3A.5

17 Jan 2024

Extension of Reset Offers and change of General Meeting date

11 Jan 2024

Reset sponsored WA Psilocybin Clinical Trial Opens

04 Jan 2024

Updated Appendix 3A.5

Previous
1
2
3
4
5
6
Next

Sign up to our newsletter

Sign up!

Quick Links

Contact Us

Head Office:
PO Box 101, Wembley,
Perth WA 6913
Ph: +61 8 6280 0050
info@littlegreenpharma.com

Follow Us

Copyright © Little Green Pharma

Site Map Privacy Search

Email Alerts

Get the latest company news

ASX Announcements

Media Releases & News

Which of the following group do you best fit?

Yes No